• Wrong document? Swap it for free
  • Written by students who passed
  • Immediately available after payment
  • Read online or as PDF
Sell
Where do you study
Your language
Start selling Create your account
Document preview thumbnail
Preview 1 out of 4 pages
Lecture notes

Biodiversity Genomics - Cancer Selection (extra examples)

Document preview thumbnail
Preview 1 out of 4 pages

Lecture notes from Imperial College London, Biological Sciences BSc, 3rd year, Biodiversity Genomics (BG) module. This document synthesises research exploring cancer resistance and evolutionary dynamics in nature, with examples drawn from three influential papers. It offers an integrated perspective on how genomic innovations and evolutionary adaptations contribute to cancer resistance and ageing across diverse species. Content Overview: The Mystery of Cancer Resistance: A Revelation Within Nature (2023) Investigates natural cancer resistance mechanisms in long-lived species, highlighting adaptations such as enhanced tumour suppression and apoptosis. Examples include elephants’ abundance of TP53 genes and the naked mole rat’s unique cellular defenses. Comparative Analysis of Bats and Rodents’ Genomes: Links to Non-LTR Retrotransposons, Cancer, and Ageing (2023) Explores the comparative genomics of bats and rodents, revealing correlations between retrotransposon activity, cancer incidence, and lifespan. Findings suggest bats’ low cancer rates may be tied to unique genomic features that suppress transposable elements and delay ageing. Long-Read Sequencing Reveals Rapid Evolution of Immunity- and Cancer-Related Genes in Bats (2023) Highlights the accelerated evolution of genes associated with immunity and cancer in bats. These adaptations enable enhanced immune responses and cellular repair mechanisms, offering a framework for understanding bats’ exceptional resilience to cancer and infectious diseases. This document is a must-read for students, providing a rich exploration of how nature’s most resilient species inform our understanding of cancer biology and evolutionary medicine.

Content preview

Lecture 6 – Papers:


The Mystery of Cancer Resistance: A Revelation Within Nature
The article discusses the mystery of cancer resistance in various animal species

Whales:
 very few cases of cancer have been found in whales and most of them are due to
environmental factors
 A genomic study in bowhead whales identified several genes under positive selection
that are linked with cancer as well as copy number gains and losses in genes
associated with cancer and aging that are involved in DNA damage repair.
 long non-coding RNAs (lncRNAs) that are strongly co-expressed with tumor
suppressors may help bowhead whales avoid cancer

Elephants have a lower risk of developing cancer due to several factors, including:
 Larger body size and longer lifespan: Despite having more cells that could potentially
become cancerous, elephants have a lower incidence of cancer than humans. This is
known as Peto's paradox and is thought to be related to the fact that elephants have
evolved multiple anticancer mechanisms to counteract this risk (Caulin and Maley
2011).
 Unique tumor suppressor genes: Elephants have 20 copies of the tumor suppressor
gene TP53, which is involved in preventing damaged cells from proliferating. This is in
contrast to most other mammals, including humans, which have only one or two
copies of TP53 (Abegglen et al. 2015). – increased number of tumour suppreoors
with larger animals
 Efficient DNA repair mechanisms: Elephants have several genes involved in DNA
damage repair that are more active than in other mammals. Additionally, some of
these genes have undergone positive selection, meaning they have evolved to be
more effective at preventing cancer (Ferris et al. 2018).

Naked mole rat exhibits cancer resistance due to several factors, including:
 Genomic stability: The naked mole rat has remained phenotypically unchanged for
30-50 million years, suggesting a high level of genomic stability that may contribute
to its cancer resistance (Bredberg and Schmitz 2019).
 Longevity genes: A set of genes under selection in the naked mole rat, including
APEX1, RFC1, and proteins TOP2A, TEP1, and TRF1, are involved in lengthening the
telomere pathway and may contribute to its longevity and cancer resistance (Kim et
al. 2011).
 Unique contact inhibition mechanisms: Unlike humans and mice, which rely on the
p27Kip1 protein for contact inhibition, the naked mole rat exhibits two-tier contact
inhibition regulated by p16Ink4a, which inhibits cell accumulation and may
contribute to its cancer resistance. Additionally, naked mole rat cells produce five
times more high-molecular mass hyaluronan (HMM-HA) than human or mouse cells,
which may interact with various cell surface receptors and trigger contact inhibition
(Seluanov et al. 2009; Tian et al. 2013).

Document information

Study
Unknown
Uploaded on
November 30, 2024
Number of pages
4
Written in
2023/2024
Type
Lecture notes
Professor(s)
Armand leroi
Contains
6
£5.46

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Sold
0
Followers
0
Items
6
Last sold
-




Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their exams and reviewed by others who've used these revision notes.

Didn't get what you expected? Choose another document

No problem! You can straightaway pick a different document that better suits what you're after.

Pay as you like, start learning straight away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and smashed it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions